Rx-360 Town Hall – Supply Chain Security and a Potential COVID-19 Vaccine with Brad Elrod, McKesson

August 27, 2020

[vc_row][vc_column][vc_video link=”https://vimeo.com/447547315″][/vc_column][/vc_row]

#Supply Chain Security Steering Committee

Rx-360 Town Hall Meeting Quality in the 21st Century – Has It Changed Due to COVID-19

June 29, 2020
#Membership #Supplier Management #Supplier Quality Working Group

Drug Supply Chain Security Act An Industry Perspective with Matthew Sample from Amerisource Bergen

June 11, 2020
#Supply Chain Security Steering Committee #Supply Chain Security Steering Committee #Supply Chain Security Steering Committee

Rx-360 Town Hall Pharmaceutical Suppliers and COVID-19, Adapting to the Pandemic

June 4, 2020
#Supplier Management #Supplier Quality Working Group

Rx-360 Town Hall Meeting COVID-19 and Pharma Counterfeiting with Aaron Graham

June 1, 2020
Webinars & Town Halls

Rx-360 Town Hall Meeting, COVID-19 and Its Impact on Pharma in the UK

May 1, 2020
#Europe Working Group
Publications

Rx-360 Supply Chain Security: Audits and Assessments of Third-Party Warehousing and Distribution Facilities Version 2.0

April 27, 2020

Pharmaceutical manufacturers and distributors frequently outsource various business functions to organizations that have a specialized expertise. While outsourcing can offer improved efficiency and cost savings, it also creates certain risks to product safety and security […]

#Supply Chain Security #Supply Chain Security #Supply Chain Security #Supply Chain Security #Supply Chain Security #Supply Chain Security #Supply Chain Security #Supply Chain Security #Supply Chain Security #Supply Chain Security
Webinars & Town Halls

Rx-360 Town Hall Meeting with Eric Marshall, Partnership for DSCSA Governance

April 20, 2020
#Membership

Rx-360 Town Hall Meeting with David Bang, Hellmann Worldwide Logistics

April 8, 2020
#SCS Logistics Security
Publications

Rx-360 Technical Paper on Tamper-Evidence and First Opening Indication

April 7, 2020

The practice of tampering and re-use of original packaging represents a significant threat in the overall landscape of counterfeit and illicit drugs. A problem, which is growing and threatens the global pharmaceutical supply chain as […]